SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer

被引:0
作者
Lutfi H. Alfarsi
Rokaya El Ansari
Madeleine L. Craze
Omar J. Mohammed
Brendah K. Masisi
Ian O. Ellis
Emad A. Rakha
Andrew R. Green
机构
[1] University of Nottingham,Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute
[2] University Park,Cellular Pathology
[3] Nottingham University Hospitals NHS Trust,undefined
[4] Nottingham City Hospital,undefined
来源
Breast Cancer Research and Treatment | 2021年 / 189卷
关键词
SLC1A5; Tamoxifen resistance; ER; Breast cancer; TALDO1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:317 / 331
页数:14
相关论文
共 182 条
[1]  
Rondón-Lagos M(2015)Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Lancet (London, England) 386 1341-1352
[2]  
Villegas VE(2016)Tamoxifen resistance: emerging molecular targets Int J Mol Sci 17 1357-674
[3]  
Rangel N(2011)Hallmarks of cancer: the next generation Cell 144 646-190
[4]  
Sánchez MC(2018)Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations Histopathology 72 183-266
[5]  
Zaphiropoulos PG(2005)Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15 254-1788
[6]  
Hanahan D(2015)Amino acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs Cancer Res 75 1782-570
[7]  
Weinberg RA(2013)SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival Clin Cancer Res 19 560-3532
[8]  
El Ansari R(2013)Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia Blood 122 3521-289
[9]  
McIntyre A(2015)Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development J Pathol 236 278-1071
[10]  
Craze ML(2014)Targeting glutamine transport to suppress melanoma cell growth Int J Cancer 135 1060-243